240 related articles for article (PubMed ID: 23055724)
1. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.
Yuan H; Bao X; Du YZ; You J; Hu FQ
Int J Nanomedicine; 2012; 7():5119-28. PubMed ID: 23055724
[TBL] [Abstract][Full Text] [Related]
2. Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system.
Xie YT; Du YZ; Yuan H; Hu FQ
Int J Nanomedicine; 2012; 7():3235-44. PubMed ID: 22802685
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
4. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Hu FQ; Wu XL; Du YZ; You J; Yuan H
Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
Ye YQ; Chen FY; Wu QA; Hu FQ; Du YZ; Yuan H; Yu HY
J Pharm Sci; 2009 Feb; 98(2):704-12. PubMed ID: 18563810
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles.
Du YZ; Cai LL; Li J; Zhao MD; Chen FY; Yuan H; Hu FQ
Int J Nanomedicine; 2011; 6():1559-68. PubMed ID: 21845046
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
8. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption.
Yuan H; Lu LJ; Du YZ; Hu FQ
Mol Pharm; 2011 Feb; 8(1):225-38. PubMed ID: 21138243
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
[TBL] [Abstract][Full Text] [Related]
10. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
[TBL] [Abstract][Full Text] [Related]
11. TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting.
Chen FY; Yan JJ; Yi HX; Hu FQ; Du YZ; Yuan H; You J; Zhao MD
Int J Nanomedicine; 2014; 9():4597-608. PubMed ID: 25298734
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.
Yu J; Xie X; Zheng M; Yu L; Zhang L; Zhao J; Jiang D; Che X
Int J Nanomedicine; 2012; 7():5079-90. PubMed ID: 23049255
[TBL] [Abstract][Full Text] [Related]
13. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of glycyrrhetinic acid-modified stearic acid-grafted chitosan micelles.
Chen Q; Sun Y; Wang J; Yan G; Cui Z; Yin H; Wei H
Artif Cells Nanomed Biotechnol; 2015; 43(4):217-23. PubMed ID: 24093764
[TBL] [Abstract][Full Text] [Related]
15. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells.
Cai LL; Liu P; Li X; Huang X; Ye YQ; Chen FY; Yuan H; Hu FQ; Du YZ
Int J Nanomedicine; 2011; 6():3499-508. PubMed ID: 22282676
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of galactosylated glycol chitosan micelles and its potential use for hepatoma-targeting delivery of doxorubicin.
Yu JM; Li WD; Lu L; Zhou XY; Wang DY; Li HM; Xu XY; Chen J
J Mater Sci Mater Med; 2014 Mar; 25(3):691-701. PubMed ID: 24338380
[TBL] [Abstract][Full Text] [Related]
17. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid.
Tian Q; Wang XH; Wang W; Zhang CN; Wang P; Yuan Z
Nanomedicine; 2012 Aug; 8(6):870-9. PubMed ID: 22100756
[TBL] [Abstract][Full Text] [Related]
20. Efficient gene delivery system mediated by cis-aconitate-modified chitosan-g-stearic acid micelles.
Yao JJ; Du YZ; Yuan H; You J; Hu FQ
Int J Nanomedicine; 2014; 9():2993-3003. PubMed ID: 24971010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
